Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

PURPOSE: This phase II trial was designed to assess the efficacy and safety of cetuximab, gemcitabine, and oxaliplatin followed by cetuximab, capecitabine, and radiation therapy in locally advanced pancreatic cancer (LAPC). PATIENTS AND METHODS: Treatment-naive eligible patients (n = 69) received in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Crane, Christopher H., Varadhachary, Gauri R., Yordy, John S., Staerkel, Gregg A., Javle, Milind M., Safran, Howard, Haque, Waqar, Hobbs, Bridgett D., Krishnan, Sunil, Fleming, Jason B., Das, Prajnan, Lee, Jeffrey E., Abbruzzese, James L., Wolff, Robert A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2011
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3157965/
https://ncbi.nlm.nih.gov/pubmed/21709185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.8038
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg